Carlyle Group reports 20.6% stake in Medline
The Carlyle Group Inc. and affiliated reporting persons filed an amendment to a Schedule 13G disclosing beneficial ownership of Medline Inc. Class A common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Carlyle Group Inc. and affiliated reporting persons filed an amendment to a Schedule 13G disclosing beneficial ownership of Medline Inc. Class A common stock. The filing reports shared dispositive power of 187,083,713 shares (20.6%) held by certain Carlyle entities and additional shared positions of 145,591,597 shares (16.3%). The ownership disclosure cites 845,611,435 shares outstanding as of April 13, 2026 per the issuer's proxy statement and itemizes entity holdings such as 97,307,792, 50,719,101 and 48,283,805 shares among other affiliated funds and holdco vehicles. The amendment clarifies the fund/GP structure through which these positions are held and shared among reporting entities.
Insights
Large, concentrated holdings by Carlyle funds are disclosed, showing substantial shared dispositive power.
The amendment documents that multiple Carlyle-managed entities together exercise shared dispositive power over 187,083,713 shares (a 20.6% stake) and another group over 145,591,597 shares (16.3%), with the issuer's outstanding shares listed as 845,611,435 as of April 13, 2026. The filing emphasizes ownership through layered GP/LP and holdco structures rather than direct individual holdings.
Implications depend on holder decisions; the disclosure is primarily informational and establishes the public ownership footprint. Subsequent filings or proxy materials may clarify voting coordination, but timing and any planned transactions are not provided in the excerpt.
Key Figures
Key Terms
beneficial ownership regulatory
common units financial
general partner (GP) legal
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Carlyle report in Medline (MDLN)?
Which Carlyle entities hold significant Medline positions?
Is the ownership figure adjusted for conversion of common units?
AI-generated analysis. How Rhea-AI works. Not financial advice.